TrialBMC nephrology2016

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Gerald Schulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.